JAPAN CLINICAL ONCOLOGY GROUP
JCOG 0403
A PHASE II STUDY OF STEREOTACTIC BODY RADIATION THERAPY IN PATIENTS WITH T1N0M0 NON-SMALL CELL LUNG CANCER

Institutions participating in protocol JCOG 0403 submit digital data representing CT images, structure sets, treatment plans, 3D dose distributions, and DVHs to Dr. Satoshi ISHIKURA, Director of the Radiotherapy Support Center, Tokyo, JAPAN.

Dr. Ishikura forwards these data to the Image-guided Therapy QA Center (ITC) in St. Louis, Missouri, USA for processing. Data are reviewed by Dr. Ishikura or his delegate using the ITC Remote Review Tool.

Currently, 15 institutions are eligible to enroll patients and capable of digital data submission on JCOG 0403.

Institution Location RTP System Approval Date
Cancer Institute Hospital Tokyo, Japan Varian Eclipse Aug 11, 2005
Hiroshima University Hiroshima, Japan Philips Pinnacle3 Nov 5, 2004
Hokkaido University Sapporo, Japan CMS FOCUS/Xio Aug 11, 2004
Institute of Biomedical Research and Innovation Kobe, Japan CMS FOCUS/Xio Aug 6, 2004
Keio University Tokyo, Japan CMS FOCUS/Xio Nov 2, 2004
Kitasato University Sagamihara, Japan Philips Pinnacle3 Dec 27, 2004
Kyoto University Kyoto, Japan Varian Eclipse Aug 25, 2004
Kyushu University Fukuoka, Japan Varian Eclipse Nov 24, 2004
Nihon University Tokyo, Japan CMS FOCUS/Xio Oct 21, 2004
Sapporo Medical University Sapporo, Japan CMS FOCUS/Xio Sep 27, 2004
Tohoku University Sendai, Japan Varian Eclipse Oct 1, 2004
Tokyo Metropolitan Komagome Hospital Tokyo, Japan CMS FOCUS/Xio Sep 3, 2004
Tokyo University Tokyo, Japan Philips Pinnacle3Feb 14, 2006
Tokyo Women's Medical University Tokyo, Japan CMS FOCUS/Xio Dec 27, 2004
University of Yamanashi Tamaho, Japan CMS FOCUS/Xio Jul 29, 2004


This page maintained by Walter R. Bosch.

Last modified: